By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NanoString Technologies today said that it has raised $20 million in a Series D round of financing.

Among the new investors in the firm is GE, through its healthymagination Fund, as well as former Genzyme Chairman and CEO Henri Termeer. All previous investors in the firm, including Clarus Ventures, Draper Fisher Jurvetson, and OVP Venture Partners, also participated in the financing round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.